{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T19:28:26Z","timestamp":1777750106368,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2017-2096"],"award-info":[{"award-number":["PICT 2017-2096"]}],"id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2021-I-A-00512"],"award-info":[{"award-number":["PICT 2021-I-A-00512"]}],"id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007757","name":"Agencia Canaria de Investigaci\u00f3n, Innovaci\u00f3n y Sociedad de la Informaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007757","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009573","name":"Universidad Nacional de Rosario","doi-asserted-by":"publisher","award":["80020190300101UR"],"award-info":[{"award-number":["80020190300101UR"]}],"id":[{"id":"10.13039\/100009573","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012637","name":"University of the East","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIP 2021\u20132023 11220200101045CO"],"award-info":[{"award-number":["PIP 2021\u20132023 11220200101045CO"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015890","name":"Agencia Santafesina de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PEICID-2021-136"],"award-info":[{"award-number":["PEICID-2021-136"]}],"id":[{"id":"10.13039\/501100015890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021778","name":"ANPCyT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.bmc.2023.117417","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T11:47:23Z","timestamp":1689594443000},"page":"117417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Lipophilic modification of salirasib modulates the antiproliferative and antimigratory activity"],"prefix":"10.1016","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5598-6060","authenticated-orcid":false,"given":"Mar\u00eda Sol","family":"Ballari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7463-1468","authenticated-orcid":false,"given":"Exequiel","family":"O. J. Porta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn Arel","family":"Zalazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla M. Borini","family":"Etichetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6268-6552","authenticated-orcid":false,"given":"Jos\u00e9 M.","family":"Padr\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5597-1865","authenticated-orcid":false,"given":"Javier E.","family":"Girardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2467-1573","authenticated-orcid":false,"given":"Guillermo R.","family":"Labadie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2023.117417_b0005","unstructured":"International Agency for Research on Cancer - WHO. Global Cancer Observatory. https:\/\/gco.iarc.fr\/. https:\/\/gco.iarc.fr\/."},{"key":"10.1016\/j.bmc.2023.117417_b0010","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.3389\/fonc.2020.595034","article-title":"Beyond the mevalonate pathway: control of post-prenylation processing by mutant p53","volume":"10","author":"Borini Etichetti","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.bmc.2023.117417_b0015","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrc3151","article-title":"Targeting protein prenylation for cancer therapy","volume":"11","author":"Berndt","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmc.2023.117417_b0020","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s00726-017-2454-x","article-title":"Isoprenyl carboxyl methyltransferase inhibitors: a brief review including recent patents","volume":"49","author":"Yang","year":"2017","journal-title":"Amino Acids"},{"key":"10.1016\/j.bmc.2023.117417_b0025","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/21541248.2017.1415637","article-title":"Small change, big effect: taking RAS by the tail through suppression of post-prenylation carboxylmethylation","volume":"11","author":"Lau","year":"2018","journal-title":"Small GTPases."},{"key":"10.1016\/j.bmc.2023.117417_b0030","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1158\/0008-5472.CAN-19-3682","article-title":"The frequency of ras mutations in cancer","volume":"80","author":"Prior","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmc.2023.117417_b0035","doi-asserted-by":"crossref","first-page":"27964","DOI":"10.1074\/jbc.M109.025296","article-title":"Role of isoprenylcysteine carboxylmethyltransferase-catalyzed methylation in rho function and migration","volume":"284","author":"Cushman","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2023.117417_b0040","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41418-018-0246-9","article-title":"Mutant p53 as a guardian of the cancer cell","volume":"26","author":"Mantovani","year":"2019","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.bmc.2023.117417_b0045","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1074\/jbc.RA118.006037","article-title":"Isoprenylcysteine carboxy methyltransferase (ICMT) is associated with tumor aggressiveness and its expression is controlled by the p53 tumor suppressor","volume":"294","author":"Etichetti","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2023.117417_b0050","doi-asserted-by":"crossref","first-page":"6584","DOI":"10.1038\/sj.onc.1204146","article-title":"Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studies","volume":"19","author":"Sebti","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.bmc.2023.117417_b0055","unstructured":"Study of Tipifarnib in Patients With Previously-Treated, Advanced, HRAS Mutant Urothelial Carcinoma. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02535650."},{"key":"10.1016\/j.bmc.2023.117417_b0060","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.bmc.2015.11.043","article-title":"8-Hydroxyquinoline-based inhibitors of the Rce1 protease disrupt Ras membrane localization in human cells","volume":"24","author":"Mohammed","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2023.117417_b0065","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1182\/blood-2006-05-024752","article-title":"Rce1 deficiency accelerates the development of K-RAS-induced myeloproliferative disease","volume":"109","author":"Wahlstrom","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bmc.2023.117417_b0070","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1073\/pnas.0408107102","article-title":"A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells","volume":"102","author":"Winter-Vann","year":"2005","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2023.117417_b0075","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1021\/jm00008a004","article-title":"Farnesyl derivatives of rigid carboxylic acids-inhibitors of ras-dependent cell growth","volume":"38","author":"Marciano","year":"1995","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117417_b0080","doi-asserted-by":"crossref","first-page":"22263","DOI":"10.1074\/jbc.270.38.22263","article-title":"Selective inhibition of ras-dependent cell growth by farnesylthiosalisylic acid","volume":"270","author":"Marom","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2023.117417_b0085","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.1021\/acs.jmedchem.9b00145","article-title":"A potent isoprenylcysteine carboxylmethyltransferase (ICMT) inhibitor improves survival in ras-driven acute myeloid leukemia","volume":"62","author":"Mar\u00edn-Ramos","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117417_b0090","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1021\/jm200249a","article-title":"Discovery and SAR of methylated tetrahydropyranyl derivatives as inhibitors of isoprenylcysteine carboxyl methyltransferase (ICMT)","volume":"54","author":"Judd","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117417_b0095","first-page":"228","article-title":"Targeting of K-Ras 4B by S-trans, trans-farnesyl thiosalicylic acid","volume":"1452","author":"Elad","year":"1999","journal-title":"BBA"},{"key":"10.1016\/j.bmc.2023.117417_b0100","first-page":"555","article-title":"The ras inhibitor S-trans, trans-farnesylthiosalicylic acid chemosensitizes human tumor cells without causing resistance","volume":"8","author":"Gana-Weisz","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmc.2023.117417_b0105","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00280-018-3618-4","article-title":"An early clinical trial of Salirasib, an oral RAS inhibitor, in Japanese patients with relapsed\/refractory solid tumors","volume":"82","author":"Furuse","year":"2018","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bmc.2023.117417_b0110","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/JTO.0b013e318223c099","article-title":"A phase II trial of salirasib in patients with lung adenocarcinomas with KRAS mutations","volume":"6","author":"Riely","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.bmc.2023.117417_b0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1021\/ml200106d","article-title":"S -farnesyl-thiopropionic acid triazoles as potent inhibitors of isoprenylcysteine carboxyl methyltransferase","volume":"3","author":"Bergman","year":"2012","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117417_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118823","article-title":"Solanesol derived therapeutic carriers for anticancer drug delivery","volume":"572","author":"Xiong","year":"2019","journal-title":"Int J Pharm"},{"key":"10.1016\/j.bmc.2023.117417_b0125","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1039\/C9MD00298G","article-title":"Repositioning Salirasib as a new antimalarial agent","volume":"10","author":"Porta","year":"2019","journal-title":"Medchemcomm."},{"key":"10.1016\/j.bmc.2023.117417_b0130","doi-asserted-by":"crossref","first-page":"47527","DOI":"10.1039\/C7RA09759J","article-title":"Experimental and theoretical studies of the [3,3]-sigmatropic rearrangement of prenyl azides","volume":"7","author":"Porta","year":"2017","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmc.2023.117417_b0135","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1039\/C7MD00008A","article-title":"Antitrypanosomal and antileishmanial activity of prenyl-1,2,3-triazoles","volume":"8","author":"Porta","year":"2017","journal-title":"Medchemcomm."},{"key":"10.1016\/j.bmc.2023.117417_b0140","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gky1075","article-title":"ChEMBL: towards direct deposition of bioassay data","volume":"47","author":"Mendez","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmc.2023.117417_b0145","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/ci500588j","article-title":"DataWarrior: an open-source program for chemistry aware data visualization and analysis","volume":"55","author":"Sander","year":"2015","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmc.2023.117417_b0150","unstructured":"Signum Biosciences Inc, Voronkov M, Stock J, et al. Anti-inflamatory complexes. 2010, WO\/2010\/090845."},{"key":"10.1016\/j.bmc.2023.117417_b0155","unstructured":"Signum Biosciences Inc, Voronkov M, Perez E, Healy J, Fernandez J. Compounds and methods use. 2018, WO\/2018\/132759A1."},{"key":"10.1016\/j.bmc.2023.117417_b0160","first-page":"725","article-title":"HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer","volume":"53","author":"Sugita","year":"2018","journal-title":"Int J Oncol"},{"key":"10.1016\/j.bmc.2023.117417_b0165","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-017-0583-4","article-title":"Combined targeting of Arf1 and Ras potentiates anticancer activity for prostate cancer therapeutics","volume":"36","author":"Lang","year":"2017","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.bmc.2023.117417_b0170","unstructured":"ChemAxon Calculator and Predictors. https:\/\/chemaxon.com\/ products\/calculators-and-predictors."},{"key":"10.1016\/j.bmc.2023.117417_b0175","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2023.117417_b0180","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1093\/nar\/gki524","article-title":"TM-align: a protein structure alignment algorithm based on the TM-score","volume":"33","author":"Zhang","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmc.2023.117417_b0185","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1128\/MCB.01719-08","article-title":"Topology of mammalian isoprenylcysteine carboxyl methyltransferase determined in live cells with a fluorescent probe","volume":"29","author":"Wright","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bmc.2023.117417_b0190","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nature25439","article-title":"Atomic structure of the eukaryotic intramembrane RAS methyltransferase ICMT","volume":"553","author":"Diver","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2023.117417_b0195","doi-asserted-by":"crossref","first-page":"17823","DOI":"10.1074\/jbc.M112.356576","article-title":"Selective inhibition of biotin protein ligase from Staphylococcus aureus","volume":"287","author":"Soares Da Costa","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2023.117417_b0200","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1021\/jm501963e","article-title":"Structure enabled design of BaZ2-ICR, a chemical probe targeting the bromodomains of BaZ2a and BaZ2B","volume":"58","author":"Drouin","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117417_b0205","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ejmech.2016.09.086","article-title":"Antitubercular activity of 1,2,3-triazolyl fatty acid derivatives","volume":"125","author":"Ghiano","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117417_b0210","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2023.117417_b0215","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13321-018-0324-5","article-title":"BioTransformer: a comprehensive computational tool for small molecule metabolism prediction and metabolite identification","volume":"11","author":"Djoumbou-Feunang","year":"2019","journal-title":"J Cheminform."},{"key":"10.1016\/j.bmc.2023.117417_b0220","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117417_b0225","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2162-3619-1-10","article-title":"Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis","volume":"1","author":"Rafiyath","year":"2012","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.bmc.2023.117417_b0230","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bmc.2023.117417_b0235","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","article-title":"New colorimetric cytotoxicity assay for anticancer-drug screening","volume":"82","author":"Skehan","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bmc.2023.117417_b0240","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/cmdc.200500057","article-title":"Prins-type synthesis and SAR study of cytotoxic alkyl chloro dihydropyrans","volume":"1","author":"Miranda","year":"2006","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2023.117417_b0245","doi-asserted-by":"crossref","first-page":"W612","DOI":"10.1093\/nar\/gkv352","article-title":"ChEMBL web services: Streamlining access to drug discovery data and utilities","volume":"43","author":"Davies","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmc.2023.117417_b0250","doi-asserted-by":"crossref","first-page":"W270","DOI":"10.1093\/nar\/gkr366","article-title":"SwissDock, a protein-small molecule docking web service based on EADock DSS","volume":"39","author":"Grosdidier","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmc.2023.117417_b0255","doi-asserted-by":"crossref","first-page":"D170","DOI":"10.1093\/nar\/gkw1081","article-title":"Uniclust databases of clustered and deeply annotated protein sequences and alignments","volume":"45","author":"Mirdita","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmc.2023.117417_b0260","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX : structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623002651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623002651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:22:54Z","timestamp":1760836974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089623002651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":52,"alternative-id":["S0968089623002651"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117417","relation":{"has-preprint":[{"id-type":"doi","id":"10.26434\/chemrxiv-2021-gkff1-v2","asserted-by":"object"}]},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipophilic modification of salirasib modulates the antiproliferative and antimigratory activity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117417","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117417"}}